Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950-II and RC-3095 on MCF-7 MIII human breast cancer xenografts in nude mice
- 1 January 1994
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 48 (10) , 465-472
- https://doi.org/10.1016/0753-3322(94)90007-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cancer statistics, 1992CA: A Cancer Journal for Clinicians, 1992
- Mastoparan, a novel mitogen for Swiss 3T3 cells, stimulates pertussis toxin-sensitive arachidonic acid release without inositol phosphate accumulation.The Journal of cell biology, 1991
- Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfallsJournal of Endocrinology, 1991
- Characterization, in some human breast cancer cell lines, of gastrin‐releasing peptide‐like receptors which are absent in normal breast epithelial cellsInternational Journal of Cancer, 1990
- The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancerJournal of Endocrinology, 1989
- Influence of Cholecystokinin Antagonist on the Effects of Cholecystokinin and Bombesin on Azaserine-Induced Lesions in Rat PancreasGastroenterology, 1989
- Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxinExperimental Cell Research, 1986
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985
- Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.BMJ, 1985
- Bombesin, neurotensin and pro-γ-melanotropin immunoreactants in human milkRegulatory Peptides, 1985